Site Reference ID/Investigator# 25030

Site Reference ID/Investigator# 25030Chicago, Illinois - 60637 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS3
- SINCE2010

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer
February 2010 - March 2012
Ovarian Neoplasms
Temozolomide
Abt-888
Pegylated Liposomal Doxorubicin



